Menu

Search

Richard Faragher

Richard Faragher

Richard Faragher is Professor of Biogerontology at the University of Brighton and is past Chair of both the British Society for Research on Ageing and the International Association of Biomedical Gerontology. He read Biochemistry at Imperial College, London and undertook doctoral studies at the University of Sussex. His primary research interest is the relationship between cellular senescence and organismal ageing.

In 2002 his work on the accelerated ageing disease Werner’s syndrome led to the award of the Royal Pharmaceutical Society Conference Science Medal for outstanding scientific achievement. In 2005 he became the first ever scientist to receive a Help the Aged award for his championship of older people and the use of research for their benefit. In 2010, he became the first ever British recipient of the Paul F Glenn Award for research into the biological mechanisms of the ageing process. He is a visiting Professor at the Moscow Institute of Physics and Technology and serves on the Editorial Boards of "Age" and "Mechanisms of aging and development".

Professor Faragher has served as a member of the Research Advisory Council of the Charity Research into Ageing and on strategy and funding panels for the BBSRC, the US National Institutes on Ageing and the European Union. From 2005-2008 he was Co-director of the BBSRC-EPSRC SPARC programme, a research network designed to build national capacity to conduct inter-disciplinary ageing research. He is currently Chair of the Scientific Advisory Board of the British Society for Research on Ageing and a member of the Board of Directors of the American Aging Association. In 2015 he became president-elect of the latter society and the first British citizen to be elected to the Board of Directors of the American Federation for Aging Research, the leading US non-profit organization supporting and advancing healthy aging through biomedical research.

Is austerity really to blame for stalling life expectancy in England?

Jul 20, 2017 16:07 pm UTC| Insights & Views Life

Over the 20th century, life expectancy in the UK increased from 46 to 76 years. But since 2010, that rate of increase is close to having ground to a halt. At any point in living memory this finding would cause serious...

Queen Elizabeth II at 90: does old age affect a monarch's ability to reign?

Apr 20, 2016 05:50 am UTC| Insights & Views Politics

Modern British monarchs may have it easier than their forebears but strength, intelligence and a hearty constitution are just as necessary today as they were in the Middle Ages. This may seem surprising. After all, as a...

1 

Economy

Dollar Rises Amid Trade Deal Uncertainty, Yen and Franc Strengthen

The U.S. dollar edged higher Friday, rebounding from earlier losses as markets reacted to mixed signals from President Donald Trump on trade talks and monetary policy. The greenback has swung sharply this week, falling 1%...

Asian Tech Stocks Climb on Alphabet Earnings and AI Optimism

Asian stock markets mostly advanced on Friday, driven by a rally in tech shares after Alphabets strong earnings and bullish AI outlook. The U.S. tech giant beat earnings expectations and reaffirmed its commitment to...

Oil Prices Inch Up but Face Weekly Loss on OPEC+, Geopolitical Developments

Oil prices edged higher early Friday but remained on track for a weekly decline amid rising supply prospects and mixed signals on global demand. Brent crude futures rose 5 cents to $66.60 a barrel, while U.S. West Texas...

AI Stock Rally Lifts Futures as Alphabet Leads Tech Surge

U.S. stock index futures rose Thursday evening, driven by strong earnings from Alphabet Inc. and renewed investor enthusiasm for artificial intelligence (AI) and tech stocks. Alphabet (NASDAQ:GOOGL) jumped nearly 5% in...

BoJ Rate Hike Odds Rise as Tokyo Inflation Surges Beyond Expectations

Tokyos consumer inflation surged in April, reinforcing expectations that the Bank of Japan (BoJ) may raise interest rates sooner than anticipated. According to ING analysts, a sharper-than-expected rise in Tokyos core...

Politics

Japan Unveils Emergency Economic Plan to Offset U.S. Tariff Impact

Japanese Prime Minister Shigeru Ishiba announced on Friday a new emergency economic package aimed at cushioning households and industries from the effects of recent U.S. import tariffs. The relief plan, outlined in a...

Moon Jae-in Criticizes Prosecutors Amid Bribery Indictment

Former South Korean President Moon Jae-in accused the countrys prosecutors of political bias and abuse of power following his recent indictment on bribery charges. Speaking on Friday during a meeting with National Assembly...

Pentagon Removes Advisory Members Amid Strategic Shift

U.S. Defense Secretary Pete Hegseth has dismissed several members of Department of Defense advisory committees following a comprehensive 45-day internal review, according to a statement released Thursday by Pentagon...

Russia Uses North Korean Missile in Kyiv Strike, Killing 12

Ukrainian President Volodymyr Zelenskiy confirmed that a North Korean ballistic missile was used by Russia in a deadly airstrike on Kyiv, killing 12 civilians. The missile, identified as a KN-23 (KN-23A), hit a residential...

Trump Urges Putin to Halt Kyiv Missile Strikes Amid Peace Talks

At least 12 people were killed and 90 wounded after Russia launched its largest missile and drone attack on Kyiv this year, devastating buildings and sparking fires across the Ukrainian capital. The assault drew a rare...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Apple Plans to Shift All U.S. iPhone Production to India Amid China Trade Tensions

Apple Inc. (NASDAQ: AAPL) is reportedly planning to shift all iPhone assembly for the U.S. market to India as early as next year, in a strategic move to reduce reliance on China amid escalating U.S.-China trade tensions,...

Chinese AI Startup Behind Manus Raises $75M, Targets Global Expansion

Chinese AI startup Butterfly Effect, the creator of Manus AI, has raised $75 million in a funding round led by U.S.-based venture capital firm Benchmark, according to a Bloomberg report citing sources familiar with the...

Intel Sees Surge in Older Chip Demand Amid U.S.-China Trade War Fears

Intel (NASDAQ: INTC) is experiencing a rise in demand for its older-generation PC and server chips as the U.S.-China trade war intensifies, executives revealed after the companys latest earnings release. Economic...

Baidu Launches Advanced Ernie AI Models to Compete in China’s Growing AI Race

Baidu (NASDAQ:BIDU) has launched upgraded versions of its Ernie artificial intelligence models, intensifying its push in Chinas fast-evolving AI landscape. At a developer conference held in Wuhan, CEO Robin Li introduced...

South Korea Flags DeepSeek for Unauthorized Data Transfers to China and U.S.

South Koreas Personal Information Protection Commission (PIPC) has accused Chinese AI startup DeepSeek of transferring personal user data and prompt content without consent during its app launch in January 2025. The PIPC...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.